Skip to content

Evaluation of efficacy and safety of riboflavin/UVA treatment for keratoconus/keratectasia

Evaluation of efficacy and safety of riboflavin/UVA treatment for keratoconus/keratectasia - efficacy and safety of riboflavin/UVA for keratoconus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000002947
Enrollment
30
Registered
2009-12-28
Start date
2009-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratoconus, keratectasia

Interventions

Collagen fibers of the corneal stroma will be crosslinked by the combination of instillation of riboflavin solution and ultraviolet-A irradiation for 30 minutes after corneal epithelial debridement.

Sponsors

Department of Ophthalmology, Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Keratoconus or keratectasia 2. The most thinnest corneal thickness more than 400 micrometer 3. In cases with keratoconus, progression should be observed within recent 6 months. In cases with keratectasia, protrusion of the cornea should be progressed after the previous corneal refractive surgeries.

Exclusion criteria

Exclusion criteria: 1. The corneal thickness less than 400 micrometer 2. Those who implanted medical instruments, such as pacemaker. 3. Ocular diseases, such as infection, corneal scar, herpetic keratitis, and/or nystagmus 4. Systemic diseases affecting corneal would healing 5. Eyes with narrow angle. Pregnant or breast-feeding women. 6. Occupation, by which refractive surgery is not arrowed

Design outcomes

Primary

MeasureTime frame
Visual acuity, refraction, corneal curvature, corneal topography, corneal endothelial cell counts, and incidence of complications

Countries

Japan

Contacts

Public ContactNaoko Kato

Keio University School of Medicine Department of Ophthalmology, Refractive Surgery Clinic

nkato@ndmc.ac.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026